Jonathan Anderman - 01 Aug 2024 Form 3 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Sr VP, Gen Counsel & Corp Sec
Signature
/s/ Neil Lerner, attorney-in-fact
Issuer symbol
CMPX
Transactions as of
01 Aug 2024
Net transactions value
$0
Form type
3
Filing time
09 Aug 2024, 16:07:16 UTC
Next filing
14 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CMPX Common Stock 1,000 01 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CMPX Stock Option (right to buy) 01 Aug 2024 Common Stock 130,000 $4.05 Direct F1
holding CMPX Stock Option (right to buy) 01 Aug 2024 Common Stock 85,000 $3.83 Direct F2
holding CMPX Stock Option (right to buy) 01 Aug 2024 Common Stock 50,000 $2.40 Direct F3
holding CMPX Stock Option (right to buy) 01 Aug 2024 Common Stock 80,000 $3.93 Direct F4
holding CMPX Stock Option (right to buy) 01 Aug 2024 Common Stock 80,000 $1.57 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 25% on August 30, 2022, with the remaining over 36 substantially equal monthly installments starting September 30, 2022.
F2 The options vest over 48 substantially equal monthly installments starting December 16, 2021.
F3 The options vest over 48 substantially equal monthly installments starting March 18, 2022.
F4 The options vest over 48 substantially equal monthly installments starting March 8, 2023.
F5 The options vest over 48 substantially equal monthly installments starting March 9, 2024.

Remarks:

Exhibit 24 - Power of Attorney